Micronized Purified Flavonoid Fraction (MPFF)

Treatment for Hemorrhoids

Typical Dosage: Acute: 1000mg TID for 4 days, then 1000mg BID for 3 days. Chronic: 500-1000mg daily.

Effectiveness
68%
Safety Score
85%
Clinical Trials
2
Participants
7.5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
Acute: 1000mg TID for 4 days, then 1000mg BID for 3 days. Chronic: 500-1000mg daily.
Time to Effect
Days to 1 week
Treatment Duration
Acute episodes (7 days), chronic management (weeks to months)
Evidence Quality
HIGH
Number Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$400
Monitoring:$50
Side Effect Mgmt:$25
Total Annual:$475
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$4,750/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$731
Micronized Purified Flavonoid Fraction (MPFF) Outcomes

for Hemorrhoids

Efficacy Outcomes
Overall Effectiveness
+68%
Response Rate
+65%
Common Side Effects
Gastrointestinal disturbances (diarrhea, nausea)
+3%
Headache
+1%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
2 active trials recruiting for Micronized Purified Flavonoid Fraction (MPFF) in Hemorrhoids

The Efficacy of Aescin in Combination With Micronized Purified Flavonoid Fraction (MPFF) in the Control of Bleeding and Prevent Recurrence of Acute Internal Hemorrhoids, A Randomized Controlled Trial, A Pilot Study

NCT06748014ENROLLING BY INVITATIONEARLY_PHASE1
View Study
120 participants
INTERVENTIONAL
Chiang Mai, Thailand
Started: Dec 20, 2024

The Efficacy of Aescin in Combination With MPFF in the Early Control of Bleeding From Acute Internal Hemorrhoids, A Randomized Controlled Trial

NCT06363513NOT YET RECRUITINGNA
View Study
60 participants
INTERVENTIONAL
Chiang Mai, Thailand
Started: Apr 1, 2024